A patient with irritable bowel syndrome reports chronic stomach pain. The PMHNP wants to prescribe the patient an agent that will cause irrelevant nociceptive inputs from the pain to be ignored and no longer perceived as painful. Which drug will the PMHNP prescribe?
a) Pregabalin (Lyrica)
ORDER NOW FOR CUSTOMIZED SOLUTION PAPERS
b) Gabapentin (Neurontin)
c) Duloxetine (Cymbalta)
d) B and C
The PMHNP wants to use a symptom-based approach to treating a patient with fibromyalgia. How does the PMHNP go about treating this patient?
a) Prescribing the patient an agent that ignores the painful symptoms by initiating a reaction known as “fibro-fog”
b) Targeting the patient’s symptoms with anticonvulsants that inhibits gray matter loss in the dorsolateral prefrontal cortex
c) Mzatching the patient’s symptoms with the malfunctioning brain circuits and neurotransimitters that might mediate those symptoms
d) None of the above
The PMHNP is working with the student to care for a patient with diabetic peripheral neuropathic pain. The student asks the PMHNP why SSRIs are not consistently useful in treating this particular patient’s pain. What is the best response by the PMHNP?
a) “SSRIs only increase norepinephrine levels”
b) “SSRIs only increase serotonin levels”
c) “SSRIs only increase serotonin and norepinephrine levels”
d) “SSRIs do not increase serotonin or norepinephrine levels”
A patient with gambling disorder and no other psychiatric comorbidities is being treated with pharmacological agents. Which drug is the PMHNP most likely to prescribe?
Kevin is an adolescent who has been diagnosed with kleptomania. His parents are interested in seeking pharmacological treatment. What does the PMHNP tell the parents regarding his treatment options?
a) “Naltrexone may be an appropriate option to discuss”
b) “there are many medicine options that treat Kleptomania”
c) “Kevin may need to be prescribed antipsychotics to treat this illness”
d) “Lithium has proven effective for treating kleptomania”